The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 19, 2008

Filed:

Jun. 20, 2005
Applicants:

Bon-hong Min, Hanam-si, KR;

Myung-ok Park, Seoul, KR;

Min-young Kim, Daejeon, KR;

Byung-young Park, Daejeon, KR;

Boe-gwun Chun, Seongnam-si, KR;

Sang-wook Kang, Seoul, KR;

Chang-hee Moon, Daejeon, KR;

Inventors:

Bon-Hong Min, Hanam-si, KR;

Myung-Ok Park, Seoul, KR;

Min-Young Kim, Daejeon, KR;

Byung-Young Park, Daejeon, KR;

Boe-Gwun Chun, Seongnam-si, KR;

Sang-Wook Kang, Seoul, KR;

Chang-Hee Moon, Daejeon, KR;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 39/02 (2006.01); C12N 9/88 (2006.01); C12N 9/06 (2006.01); C12N 15/70 (2006.01); C12P 21/06 (2006.01); C12Q 1/34 (2006.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a pharmaceutical composition for inhibiting angiogenesis which comprises arginine deiminase as an active ingredient, where the arginine deiminase, obtained fromor prepared by a genetic recombination technique, may be conjugated to an activated polymer to lower its immunogenecity and increase its life time. The pharmaceutical composition of the present invention exhibits an excellent inhibitory activity against angiogenesis.


Find Patent Forward Citations

Loading…